Double-Blind, Placebo-Controlled Study of Single-Dose Amphetamine Formulations in ADHD-Reference-Cited by-同舟云学术

Double-Blind, Placebo-Controlled Study of Single-Dose Amphetamine Formulations in ADHD

Published:2001-11 Issue:11 Volume:40 Page:1268-1276
ISSN:0890-8567
Container-title:Journal of the American Academy of Child & Adolescent Psychiatry
language:en
Short-container-title:Journal of the American Academy of Child & Adolescent Psychiatry

Author:

JAMES REGINA S.,SHARP WENDY S.,BASTAIN THERESA M.,LEE PATTI P.,WALTER JAMES M.,CZARNOLEWSKI MARK,CASTELLANOS F. XAVIER

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Developmental and Educational Psychology

Reference24 articles.

1. The Child Behavior Checklist and related forms for assessing behavioral/emotional problems and competencies;Achenbach;Pediatr Rev,2000

2. Responders and nonresponders (letter);Arnold;J Am Acad Child Adolesc Psychiatry,1996

3. Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes’ analysis;Arnold;Arch Gen Psychiatry,1978

4. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation;Barkley;Pediatrics,1990

5. Behavior and motor activity response in hyperactive children and plasma amphetamine levels following a sustained release preparation;Brown;J Am Acad Child Psychiatry,1980

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-injury methamphetamine use is associated with increased length of hospital stay in rural orthopaedic trauma patients;Injury;2024-11

2. Amphetamine and methylphenidate potential on the recovery from stroke and traumatic brain injury: a review;Reviews in the Neurosciences;2024-06-10

3. Effect of CYP2D6 genetic variation on patient-reported symptom improvement and side effects among children and adolescents treated with amphetamines;Pharmacogenetics and Genomics;2024-03-20

4. A review of amphetamine extended release once-daily options for the management of attention-deficit hyperactivity disorder;Expert Review of Neurotherapeutics;2024-02-23

5. Stimulants;Child and Adolescent Psychiatric Clinics of North America;2022-07